The impact of pre-existing hematologic disorders on morbidity and mortality following heart transplantation: Focus on early graft dysfunction.

Autor: Carey MR; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Columbia University Irving Medical Center, New York, New York, USA., Ladanyi A; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Columbia University Irving Medical Center, New York, New York, USA., Mehlman Y; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Columbia University Irving Medical Center, New York, New York, USA., Molinsky RL; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA., Eisenberger A; Division of Hematology/Oncology, Department of Medicine, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York, USA., Clerkin KJ; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Columbia University Irving Medical Center, New York, New York, USA., Aaron JG; Division of Infectious Diseases, Department of Medicine, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York, USA., Takeda K; Division of Cardiac, Thoracic & Vascular Surgery, Department of Surgery, NewYork-Presbyterian, Columbia University Irving Medical Center, New York, New York, USA., Sayer GT; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Columbia University Irving Medical Center, New York, New York, USA., Uriel N; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Columbia University Irving Medical Center, New York, New York, USA., Demmer RT; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA., Colombo PC; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Columbia University Irving Medical Center, New York, New York, USA., Yuzefpolskaya M; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Columbia University Irving Medical Center, New York, New York, USA.

Publikováno v: Clinical transplantation [Clin Transplant] 2023 May; Vol. 37 (5), pp. e14974. Date of Electronic Publication: 2023 Mar 20.

Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment Strategy.

Autor: Lumish HS; From the Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, New York., Cagliostro B; Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota., Braghieri L; From the Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, New York., Bohn B; Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota., Mondellini GM; From the Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, New York., Antler K; Department of Surgery, Division of Cardiac Surgery, Columbia University Irving Medical Center, New York, New York., Feldman V; Department of Surgery, Division of Cardiac Surgery, Columbia University Irving Medical Center, New York, New York., Kleet A; Department of Surgery, Division of Cardiac Surgery, Columbia University Irving Medical Center, New York, New York., Murphy J; Department of Surgery, Division of Cardiac Surgery, Columbia University Irving Medical Center, New York, New York., Tiburcio M; Department of Surgery, Division of Cardiac Surgery, Columbia University Irving Medical Center, New York, New York., Fidlow K; Department of Surgery, Division of Cardiac Surgery, Columbia University Irving Medical Center, New York, New York., Jennings D; From the Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, New York., Sayer GT; From the Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, New York., Takeda K; Department of Surgery, Division of Cardiac Surgery, Columbia University Irving Medical Center, New York, New York., Naka Y; Department of Surgery, Division of Cardiac Surgery, Columbia University Irving Medical Center, New York, New York., Demmer RT; Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota.; Department of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York., Aaron JG; Department of Medicine Division of Infectious Diseases, Columbia University Irving Medical Center, New York, New York., Uriel N; From the Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, New York., Colombo PC; From the Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, New York., Yuzefpolskaya M; From the Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, New York.

Publikováno v: ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2022 Dec 01; Vol. 68 (12), pp. 1450-1458. Date of Electronic Publication: 2022 Feb 27.

Cycle Thresholds Among Solid Organ Transplant Recipients Testing Positive for SARS-CoV-2.

Autor: Theodore DA; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY., Greendyke WG; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY., Miko B; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY., Whittier S; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY., Green DA; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY., Shoucri S; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY., Verna EC; Division of Digestive and Liver Diseases, Center for Liver Disease and Transplantation, Columbia University Irving Medical Center, New York, NY., Zucker J; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY.; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY., Sobieszczyk ME; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY., Aaron JG; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY., Scully BE; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY., Saiman L; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY.; Department of Infection Prevention and Control, NewYork-Presbyterian Hospital, New York, NY., Pereira M; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY., Furuya EY; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY.; Department of Infection Prevention and Control, NewYork-Presbyterian Hospital, New York, NY.

Publikováno v: Transplantation [Transplantation] 2021 Jul 01; Vol. 105 (7), pp. 1445-1448.

Baloxavir treatment of oseltamivir-resistant influenza A/H1pdm09 in two immunocompromised patients.

Autor: Macesic N; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY, USA.; Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia., Laplante JM; Laboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA., Aaron JG; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY, USA., DiMango EA; Department of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center, New York, NY, USA., Miko BA; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY, USA., Pereira MR; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY, USA., Reshef R; Division of Hematology & Oncology, Columbia University Irving Medical Center, New York, NY, USA., St George K; Laboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA.; Department of Biomedical Science, University at Albany, Albany, NY, USA.

Publikováno v: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2021 Jun; Vol. 23 (3), pp. e13542. Date of Electronic Publication: 2020 Dec 22.

Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City.

Autor: Sepulveda J; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Westblade LF; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.; Division of Infectious Diseases, Department of Internal Medicine, Weill Cornell Medicine, New York, New York, USA., Whittier S; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Satlin MJ; Division of Infectious Diseases, Department of Internal Medicine, Weill Cornell Medicine, New York, New York, USA., Greendyke WG; Division of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA., Aaron JG; Division of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA., Zucker J; Division of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA., Dietz D; Division of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA., Sobieszczyk M; Division of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA., Choi JJ; Division of Infectious Diseases, Department of Internal Medicine, Weill Cornell Medicine, New York, New York, USA., Liu D; Department of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens Hospital, New York, New York, USA., Russell S; Clinical Laboratories, NewYork-Presbyterian Hospital, New York, New York, USA., Connelly C; Clinical Laboratories, NewYork-Presbyterian Hospital, New York, New York, USA., Green DA; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA dag2149@cumc.columbia.edu.

Publikováno v: Journal of clinical microbiology [J Clin Microbiol] 2020 Jul 23; Vol. 58 (8). Date of Electronic Publication: 2020 Jul 23 (Print Publication: 2020).